(ANAU) AXA IM Nasdaq 100 USD Acc - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE000QDFFK00

ETF, Switzerland, US Large-Cap Growth Equity, Morningstar, USD

Description: ANAU AXA IM Nasdaq 100 USD Acc

The AXA IM Nasdaq100 UCITS ETF USD Acc is an exchange-traded fund that tracks the Morningstar US LM Brd Growth NR USD Index, providing investors with exposure to US large-cap growth equities. The fund is domiciled in Switzerland and has a total assets under management (AUM) of approximately $1.055 billion USD.

From a technical analysis perspective, the ETFs price is currently at $19.02, with a short-term bullish trend indicated by its position above the 20-day Simple Moving Average (SMA) of $18.63. The 50-day SMA and 200-day SMA are at $17.44 and $17.71, respectively, suggesting a strong uptrend. The Average True Range (ATR) is $0.23, representing a 1.22% daily price movement, indicating moderate volatility. The ETFs price is near its 52-week high of $19.16 and significantly above its 52-week low of $14.87.

Given the current technical and fundamental data, a forecast for the AXA IM Nasdaq100 UCITS ETF USD Acc could be as follows: With the ETF trading near its 52-week high and above its short-term moving averages, it is likely to continue its upward momentum in the short term. However, the moderate volatility indicated by the ATR suggests that investors should be prepared for potential price swings. In the long term, the funds tracking of the Nasdaq-100 Index, which is known for its growth-oriented and technology-heavy composition, could lead to continued growth, driven by the underlying indexs performance. Therefore, a potential forecast could be a slight increase in price, potentially reaching $20.00 in the next few months, contingent on the continued positive trend in US large-cap growth equities.

Its worth noting that the funds AUM of over $1 billion USD indicates a decent level of liquidity and investor interest, which could contribute to its stability and potential for growth. As with any investment, its crucial for investors to conduct their own research and consider their risk tolerance before making any decisions.

Additional Sources for ANAU ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ANAU ETF Overview

Market Cap in USD 1,056m
Category US Large-Cap Growth Equity
TER 0.14%
IPO / Inception 2022-11-16

ANAU ETF Ratings

Growth Rating 47.0
Fundamental -
Dividend Rating 0.0
Rel. Strength -0.17
Analysts -
Fair Price Momentum 18.21 USD
Fair Price DCF -

ANAU Dividends

Currently no dividends paid

ANAU Growth Ratios

Growth Correlation 3m 95.2%
Growth Correlation 12m 43.4%
Growth Correlation 5y 85.3%
CAGR 5y 35.77%
CAGR/Max DD 5y 1.60
Sharpe Ratio 12m 1.78
Alpha 0.25
Beta 0.976
Volatility 16.32%
Current Volume 123.9k
Average Volume 20d 3.4k
What is the price of ANAU shares?
As of July 03, 2025, the stock is trading at USD 19.45 with a total of 123,932 shares traded.
Over the past week, the price has changed by +0.88%, over one month by +5.55%, over three months by +15.68% and over the past year by +13.56%.
Is AXA IM Nasdaq 100 USD Acc a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, AXA IM Nasdaq 100 USD Acc (SW:ANAU) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.03 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ANAU is around 18.21 USD . This means that ANAU is currently overvalued and has a potential downside of -6.38%.
Is ANAU a buy, sell or hold?
AXA IM Nasdaq 100 USD Acc has no consensus analysts rating.
What are the forecasts for ANAU share price target?
According to our own proprietary Forecast Model, ANAU AXA IM Nasdaq 100 USD Acc will be worth about 21.3 in July 2026. The stock is currently trading at 19.45. This means that the stock has a potential upside of +9.51%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.3 9.5%